X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-03-20 | TARS | Neervannan Seshadri | COO | S - Sale | $66.75 | -2,989 | 83,266 | -3% | -$199,516 | ||||||
| M | 2026-03-17 | TARS | Whitfield Dianne C. | CHRO | S - Sale | $68.36 | -12,274 | 35,028 | -26% | -$839,070 | |||||
| M | 2026-03-17 | TARS | Wahl Bryan | GC | S - Sale | $68.36 | -12,440 | 63,959 | -16% | -$850,417 | |||||
| M | 2026-03-17 | TARS | Neervannan Seshadri | COO | S - Sale | $68.21 | -11,324 | 86,255 | -12% | -$772,444 | |||||
| M | 2026-03-17 | TARS | Mottiwala Aziz | Chief Commercial Officer | S - Sale | $68.36 | -13,056 | 61,480 | -18% | -$892,528 | |||||
| M | 2026-03-17 | TARS | Lin Elizabeth Yeu | Chief Medical Officer | S - Sale | $68.36 | -1,144 | 41,708 | -3% | -$78,204 | |||||
| M | 2026-03-17 | TARS | Farrow Jeffrey S | See Remarks | S - Sale | $68.36 | -6,430 | 43,316 | -13% | -$439,566 | |||||
| M | 2026-03-17 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $68.34 | -34,603 | 891,412 | -4% | -$2,364,904 | |||||
2026-03-16 | TARS | Link William J Phd | Dir | S - Sale | $68.79 | -12,500 | 116,332 | -10% | -$859,819 | ||||||
2026-03-04 | TARS | Neervannan Seshadri | COO | S - Sale | $76.67 | -8,366 | 71,292 | -11% | -$641,421 | ||||||
2026-01-02 | TARS | Whitfield Dianne C. | CHRO | S - Sale | $80.67 | -15,565 | 23,393 | -40% | -$1,255,684 | ||||||
2025-12-24 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $82.51 | -6,000 | 859,741 | -1% | -$495,089 | ||||||
2025-12-16 | TARS | Whitfield Dianne C. | CHRO | S - Sale | $80.10 | -7,397 | 38,958 | -16% | -$592,500 | ||||||
2025-12-15 | TARS | Link William J Phd | Dir | S - Sale | $81.26 | -22,946 | 128,832 | -15% | -$1,864,678 | ||||||
| D | 2025-12-16 | TARS | Lin Elizabeth Yeu | Chief Medical Officer | S - Sale+OE | $79.50 | -2,078 | 40,341 | -5% | -$165,201 | |||||
2025-09-24 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $55.37 | -6,000 | 865,741 | -1% | -$332,220 | ||||||
2025-09-08 | TARS | Link William J Phd | Dir | S - Sale | $57.00 | -27,116 | 153,778 | -15% | -$1,545,612 | ||||||
2025-08-11 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $50.00 | -6,000 | 871,741 | -1% | -$300,000 | ||||||
| D | 2025-06-17 | TARS | Farrow Jeffrey S | See Remarks | S - Sale+OE | $40.42 | -13,608 | 36,704 | -27% | -$550,035 | |||||
| D | 2025-06-16 | TARS | Lin Elizabeth Yeu | Chief Medical Officer | S - Sale+OE | $41.08 | -1,006 | 35,600 | -3% | -$41,326 | |||||
2025-06-09 | TARS | Mottiwala Aziz | Chief Commercial Officer | S - Sale | $43.76 | -17,500 | 47,557 | -27% | -$765,800 | ||||||
2025-03-24 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $50.00 | -6,000 | 877,741 | -1% | -$300,000 | ||||||
| M | 2025-03-18 | TARS | Mottiwala Aziz | Chief Commercial Officer | S - Sale | $47.88 | -10,565 | 65,057 | -14% | -$505,856 | |||||
| M | 2025-03-18 | TARS | Neervannan Seshadri | COO | S - Sale | $47.89 | -7,583 | 79,682 | -9% | -$363,142 | |||||
| M | 2025-03-18 | TARS | Wahl Bryan | GC | S - Sale | $47.88 | -9,686 | 51,712 | -16% | -$463,766 | |||||
| M | 2025-03-18 | TARS | Whitfield Dianne C. | CHRO | S - Sale | $47.88 | -6,711 | 46,355 | -13% | -$321,323 | |||||
| M | 2025-03-18 | TARS | Azamian Bobak R. | Pres, CEO, Board Chair | S - Sale | $48.03 | -24,216 | 883,741 | -3% | -$1,163,050 | |||||
| M | 2025-03-18 | TARS | Farrow Jeffrey S | See Remarks | S - Sale | $47.88 | -3,724 | 22,431 | -14% | -$178,306 | |||||
2024-08-12 | TARS | Link William J Phd | Dir | S - Sale | $26.08 | -35,000 | 177,544 | -16% | -$912,961 | ||||||
| D | 2024-06-18 | TARS | Farrow Jeffrey S | See Remarks | S - Sale+OE | $27.47 | -10,445 | 18,136 | -37% | -$286,924 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |